CVE-2014-8986

Description

Cross-site scripting (XSS) vulnerability in the selection list in the filters in the Configuration Report page (adm_config_report.php) in MantisBT 1.2.13 through 1.2.17 allows remote administrators to inject arbitrary web script or HTML via a crafted config option, a different vulnerability than CVE-2014-8987.

Category

3.5
CVSS
Severity: Low
CVSS 2.0 •
EPSS 0.53%
Vendor Advisory debian.org Vendor Advisory github.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://www.openwall.com/lists/oss-security/2014/11/15/2 mailing list
http://www.openwall.com/lists/oss-security/2014/11/19/20 mailing list
http://www.openwall.com/lists/oss-security/2014/11/15/3 mailing list
http://secunia.com/advisories/62101 third party advisory
http://www.openwall.com/lists/oss-security/2014/11/15/1 mailing list
https://github.com/mantisbt/mantisbt/commit/cabacdc291c251bfde0dc2a2c945c02cef41bf40 vendor advisory
http://www.debian.org/security/2015/dsa-3120 vendor advisory

Frequently Asked Questions

What is the severity of CVE-2014-8986?
CVE-2014-8986 has been scored as a low severity vulnerability.
How to fix CVE-2014-8986?
To fix CVE-2014-8986, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2014-8986 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2014-8986 is being actively exploited. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.